Mitchel Max Awardee:
Congratulations to Dr. Aroke.
Edwin Aroke PhD, CRNA, FAAN, University of Alabama at Birmingham, Birmingham, AL
Genomic Pathways Enriched by Differentially Methylated Genes are Linked to Racial Disparities in Chronic Low Back Pain
Dr. Edwin Aroke is an Associate Professor and the Director of the Dual DNP-PhD Program at the University of Alabama at Birmingham School of Nursing. Dr. Aroke graduated from the Duke University Nurse Anesthesia Program and earned his Ph.D. from the University of Massachusetts Medical School. His program of research, funded by the NIH, uses a multi-omics approach to examine the mechanisms that cause and sustain chronic pain and racial pain disparities. Dr. Aroke has received numerous prestigious awards, including, Researcher of the Year by the American Association of Nurse Anesthesiology (AANA) Foundation, Didactic Faculty of the Year by the AANA, and a Fellow of the American Academy of Nursing.
2022 Mitchell Max Award Finalists:
Raveendhara R. Bannuru MD, PhD Tufts Medical Center, Boston, MA
Ideal Dose and Duration of Exercise Interventions to Achieve Treatment Response: An Individual-Participant Data Network Meta-Analysis Assessing the Comparative Effectiveness of Mind-Body Interventions for Knee Osteoarthritis
Dr. Bannuru is a primary care physician, received his MD from India and PhD in clinical and translational science from Tufts University. He received Dean’s award for excellence in research and Faculty of 1000 international award for excellent research for his doctoral work, which was supported by T32 and F32 grants from AHRQ. His major research interests include multiple treatment comparison methodology, clinical practice guideline development, meta-epidemiological studies, and placebo effects in chronic pain. Dr. Bannuru applied evidence synthesis and comparative effectiveness research methods in preparing knee osteoarthritis devices for the FDA’s regulatory review. Over the past few years, he served as the lead guideline methodologist for American College of Rheumatology, American Diabetes Association, Osteoarthritis Research Society International, Royal Australian College of General Practitioners, American Academy of Neurology, Infectious Diseases Society of America and WHO. Dr. Bannuru’s current work, supported by NCCIH (K23), is focused on the non-pharmacological management of chronic musculoskeletal pain. He is applying individual-patient data network meta-analysis techniques to identify what intervention works best for who, and to find the optimal dose and duration of these interventions to elicit a treatment response.
David Yarmolinsky, PhD, Boston Children’s Hospital, Boston, MA
Visualizing transformations of spinal sensory coding in neuropathic pain.
David Yarmolinsky is a Postdoctoral Fellow in Neurobiology at Boston Children’s Hospital. His research interests include the function, plasticity, and dysfunction of mammalian sensory systems. David was born in Tangier and grew up in New York, NY. He completed undergraduate work at Oberlin College in Biology and Neuroscience and received his PhD from Columbia University, where he studied the molecular and systems neurobiology of mammalian taste sensation in the laboratory of Charles Zuker. His current research in the laboratory of Clifford Woolf applies in vivo neurophotonics to investigate circuit mechanisms giving rise to neuropthic pain. This work is funded by an an K99/R00 Pathway to Independence award from the NIDCR.